Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Boya, Rakesh R
NCT03936933: Pharmacodynamic Study Goserelin 3.6mg Injection Administered Subcutaneously in Premenopausal Patients With Breast Cancer	Recruiting	3	68	RoW	Goserelin acetate 3.6 mg Injection, Goserelin acetate, ZOLADEX® 3.6mg Injection, Zoladex	Eurofarma Laboratorios S.A.	Breast Cancer	09/24	01/25
Boya, Rajesh Mr Reddy
NCT03936218: Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer	Recruiting	3	94	RoW	Inj. Goserelin (Test) Subcutaneously, Goserelin, Inj. Zoladex (Reference) Subcutaneously, Zoladex	Eurofarma Laboratorios S.A.	Advanced Prostate Cancer	11/23	06/25